286 related articles for article (PubMed ID: 27117376)
21. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
22. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
23. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
24. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
25. Can calcium ionophore "use" in patients with diminished ovarian reserve increase fertilization and pregnancy rates? A randomized, controlled study.
Caglar Aytac P; Kilicdag EB; Haydardedeoglu B; Simsek E; Cok T; Parlakgumus HA
Fertil Steril; 2015 Nov; 104(5):1168-74. PubMed ID: 26342247
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
27. Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging.
Artini PG; Obino ME; Carletti E; Pinelli S; Ruggiero M; Di Emidio G; Cela V; Tatone C
Gynecol Endocrinol; 2013 Nov; 29(11):997-1001. PubMed ID: 23909592
[TBL] [Abstract][Full Text] [Related]
28. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
29. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.
Lai TH; Lee FK; Lin TK; Horng SG; Chen SC; Chen YH; Wang PC
Fertil Steril; 2009 Aug; 92(2):508-14. PubMed ID: 18701101
[TBL] [Abstract][Full Text] [Related]
30. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
31. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
Engmann L; DiLuigi A; Schmidt D; Benadiva C; Maier D; Nulsen J
Fertil Steril; 2008 Mar; 89(3):554-61. PubMed ID: 17678651
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
33. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
[TBL] [Abstract][Full Text] [Related]
34. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
35. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching.
Rodriguez-Purata J; Coroleu B; Tur R; Carrasco B; Rodriguez I; Barri PN
Gynecol Endocrinol; 2013 Sep; 29(9):859-62. PubMed ID: 23875964
[TBL] [Abstract][Full Text] [Related]
36. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
Jurema MW; Bracero NJ; Garcia JE
Fertil Steril; 2003 Nov; 80(5):1156-61. PubMed ID: 14607567
[TBL] [Abstract][Full Text] [Related]
37. Reproductive outcomes of familial oocyte donation.
Hasson J; Tulandi T; Son WY; Al Ma'mari N; Badeghiesh A; Tannus S; Takefman J; Shavit T
Fertil Steril; 2016 Dec; 106(7):1696-1702. PubMed ID: 27678040
[TBL] [Abstract][Full Text] [Related]
38. Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders.
Drakopoulos P; Romito A; Errázuriz J; Santos-Ribeiro S; Popovic-Todorovic B; Racca A; Tournaye H; De Vos M; Blockeel C
Reprod Biomed Online; 2019 Oct; 39(4):698-703. PubMed ID: 31383604
[TBL] [Abstract][Full Text] [Related]
39. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry.
Provost MP; Acharya KS; Acharya CR; Yeh JS; Steward RG; Eaton JL; Goldfarb JM; Muasher SJ
Fertil Steril; 2016 Mar; 105(3):663-669. PubMed ID: 26627120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
